Ryan Specialty Holdings, Inc.
RYAN
$42.18
-3.85%
Ryan Specialty Holdings, Inc. is an international specialty insurance intermediary that provides wholesale brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management, across property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits. As a leading player in the specialty insurance space, it differentiates itself through its expertise in complex and hard-to-place risks, serving as a critical link between retail brokers and carriers. The current investor narrative centers on the company's growth trajectory amid a challenging market environment, with recent volatility in its stock price reflecting broader market selloffs and concerns about its valuation, while analysts remain optimistic about its long-term prospects, as evidenced by a consensus 'buy' rating and a target price implying upside.…
RYAN
Ryan Specialty Holdings, Inc.
$42.18
RYAN 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ryan Specialty Holdings, Inc.'s 12-month outlook, with a consensus price target around $50.84 and implied upside of +20.5% versus the current price.
Average Target
$50.84
0 analysts
Implied Upside
+20.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$34 - $76
Analyst target range
Ryan Specialty is covered by 16 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 2.39 (where 1 is strong buy and 5 is sell). The average target price is $49.84, which implies an upside of approximately 12.1% from the current price of $44.47. The distribution of ratings is not provided, but the consensus leans bullish, with a majority of analysts likely rating it as a buy or overweight. The target price range spans from a low of $34.00 to a high of $76.00, indicating a wide dispersion in analyst expectations. The high target of $76.00 suggests that some analysts see significant upside potential, possibly driven by expectations of accelerating growth and margin expansion, while the low target of $34.00 reflects concerns about competitive pressures or a potential downturn in the specialty insurance market. The wide spread between the low and high targets indicates high uncertainty about the company's future performance, which is typical for a growth-oriented company in a niche market. Given the recent price volatility and the stock's beta of 0.57, which is lower than the market, the stock may offer a relatively stable investment with moderate upside potential, but investors should be aware of the risks highlighted by the low target price.
RYAN Technical Analysis
RYAN's price trend over the past year has been predominantly downward, with a 1-year price change of -22.49%, and the stock is currently trading at $44.47, which is approximately 73% of its 52-week range (between $29.28 and $61.05). This positioning near the lower end of its range suggests that the stock is in a recovery phase after a significant decline, but it has not yet reclaimed its previous highs, indicating lingering bearish sentiment. The 52-week low of $29.28 was reached in May 2026, and the stock has since rebounded, but it remains well below its 52-week high of $61.05, reflecting a substantial drawdown of -56.24% from peak to trough.
Beta
0.57
0.57x market volatility
Max Drawdown
-55.1%
Largest decline past year
52-Week Range
$29-$59
Price range past year
Annual Return
-25.4%
Cumulative gain past year
| Period | RYAN Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | +2.7% |
| 3m | +30.6% | +1.0% |
| 6m | +6.8% | +12.0% |
| 1y | -25.4% | +18.9% |
| ytd | -16.7% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RYAN Fundamental Analysis
Ryan Specialty's revenue trajectory has been robust, with the most recent quarterly revenue estimated at $3.84 billion (based on analyst estimates), reflecting a strong growth rate of approximately 20% year-over-year, driven by expansion in its wholesale brokerage and delegated underwriting segments. The company's gross margin is exceptionally high at 90.58%, indicating a highly scalable business model with minimal cost of goods sold, and its operating margin of 20.49% demonstrates efficient cost management. Net income is positive, with an EPS of $0.0096, and the net margin is 2.08%, which is relatively low but improving as the company scales. The company's profitability is supported by a strong ROE of 9.78% and ROA of 3.45%, indicating effective use of equity and assets to generate returns.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RYAN Overvalued?
Given that Ryan Specialty has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 103.26x, while the forward PE is 18.47x, implying that the market expects significant earnings growth in the coming year, which is consistent with the company's growth trajectory. The gap between trailing and forward PE suggests that the market is pricing in a substantial improvement in profitability, which is a positive signal if the company can deliver on its growth targets. Compared to the industry average, Ryan Specialty's forward PE of 18.47x is at a premium to the sector average of approximately 15x, reflecting a 23% premium, which is justified by its superior growth prospects and high margins. Historically, the stock's PE has ranged widely, and the current forward PE is near the lower end of its historical band, suggesting that the stock may be undervalued relative to its own history, especially if the company can achieve its earnings estimates.
PE
103.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.4x
Enterprise Value Multiple